mdlinx mdlinx

Psychiatry News & Articles

MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (44) Full Text Articles (1263) Focus on Substance Abuse
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

981 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013    Clinical Article

982 Individual music therapy for agitation in dementia: an exploratory randomized controlled trial Aging and Mental Health, April 29, 2013    Clinical Article

983 Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism Prenatal Valproate and Autism JAMA, April 29, 2013    Clinical Article

984 Effects of physical exercise on plasma levels of brain-derived neurotrophic factor and depressive symptoms in elderly women ? a randomized clinical trial Archives of Physical Medicine and Rehabilitation, April 29, 2013    Clinical Article

985 Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: A meta-analysis and cochrane review of randomized controlled trials European Neuropsychopharmacology, April 29, 2013    Evidence Based Medicine    Review Article    Clinical Article

986 A systematic review of psychostimulant treatment of negative symptoms of schizophrenia: Challenges and therapeutic opportunities Schizophrenia Research, April 29, 2013    Evidence Based Medicine    Review Article

987 Side effects associated with psychotropic medications in patients with bipolar disorder: evidence from two independent samples Journal of Psychopharmacology, April 29, 2013    Clinical Article

988 Depressive Symptomatology as a Risk Factor for Falls in Older People: Systematic Review and Meta-Analysis Journal of the American Geriatrics Society, April 29, 2013    Evidence Based Medicine    Review Article

989 Structural and Functional Neuroimaging Studies in Major Depressive Disorder With Psychotic Features: A Critical Review Schizophrenia Bulletin, April 29, 2013    Review Article

990 Physical comorbidities in men with mood and anxiety disorders: a population-based study Full Text BMC Medicine, April 29, 2013

991 Cognitive impairment before and six months after cardiac surgery increase mortality risk at median 11year follow-up: a cohort study International Journal of Cardiology, April 29, 2013    Clinical Article

992 Dwelling on potential threat cues: an eye movement marker for combat-related PTSD Depression and Anxiety, April 29, 2013    Clinical Article

993 Conduct Disorder and Initiation of Substance Use: A Prospective Longitudinal Study Journal of the American Academy of Child & Adolescent Psychiatry, April 29, 2013    Clinical Article

994 Effects of Depression Diagnosis and Antidepressant Treatment on Mortality in Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease Journal of the American Geriatrics Society, April 29, 2013    Clinical Article

995 Systematic review of non-pharmacologic interventions to delay functional decline in community-dwelling patients with dementia Aging and Mental Health, April 29, 2013    Evidence Based Medicine    Review Article

996 Atypical neuropsychological profiles and cognitive outcome in mesial temporal lobe epilepsy Epilepsy & Behavior, April 29, 2013    Clinical Article

997 Tryptophan Metabolism and Immunogenetics in Major Depression: A role for interferon-γ gene Brain, Behavior, and Immunity, April 29, 2013    Clinical Article

998 Targeted versus tailored multimedia patient engagement to enhance depression recognition and treatment in primary care: randomized controlled trial protocol for the AMEP2 study Full Text BMC Health Services Research, April 29, 2013    Clinical Article

999 Sensitivity and Specificity of the Screen for Child Anxiety Related Emotional Disorders (SCARED): A Community-Based Study Child Psychiatry and Human Development, April 29, 2013    Clinical Article

1000 Parenting Stress and Child Behavior Problems Among Clinic-Referred Youth: Cross-Cultural Differences Across the US and Korea Child Psychiatry and Human Development, April 29, 2013    Clinical Article

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 NextLast

Clinical Pearls in Psychiatry

Highlights in Psychiatry

Risk factors for postpartum depression

As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).

Read the article summary

A link between cardiovascular fitness and depression

As published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).

Read the article summary

Optimal dose of amisulpride for acute exacerbation of schizophrenia

As published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2012

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close